Internal Medicine · Pasadena, TX
NPI
1083797799
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5030 Crenshaw Rd, Suite 120
Pasadena, TX, 77505
Phone (713) 941-3798
Groups this clinician bills Medicare through
Medicare paid, 2024
$284K
207,476 services
Medicare patients, 2024
435
Average age 74
Drug cost, 2024
$1.1M
15,070 prescriptions
Company payments, 2025
$15.11
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kent D Schnell was code J1071 (injection, testosterone cypionate, 1 mg), 188,316 times for 97 patients. In total Kent D Schnell billed 207,476 services in 60 codes, and Medicare paid $284K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 188,316 | 97 | $0.02 | $3,206 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 4,932 | 252 | $0.68 | $3,346 |
| 96372 Injection Administration | Office | 3,373 | 295 | $10.08 | $34K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 2,098 | 98 | $0.53 | $1,118 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,600 | 20 | $0.10 | $153 |
| 99213 Office E&M - Established | Office | 1,527 | 278 | $63.21 | $97K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 1,118 | 155 | $0.88 | $987 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,100 | 54 | $0.07 | $77.28 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,049 | 149 | $0.32 | $332 |
| 99214 Office E&M - Established | Office | 631 | 272 | $84.70 | $53K |
| 99232 Hospital E&M - Subsequent | Facility | 516 | 89 | $62.68 | $32K |
| J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 260 | 98 | $0.02 | $4.18 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 197 | 197 | $129.29 | $25K |
| 90656 Vaccine Product | Office | 87 | 86 | $21.40 | $1,862 |
| G0008 Administration of influenza virus vaccine | Office | 84 | 82 | $32.36 | $2,718 |
By year: 2022 $295K for 186,972 services; 2023 $261K for 173,449 services; 2024 $284K for 207,476 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 73 | 49 | $3.89 | $284 |
| 87428 Infectious Agent Detection by DNA/RNA | 67 | 52 | $63.62 | $4,262 |
| 82570 Clinical Chemistry | 12 | 11 | $5.08 | $60.96 |
Medicare prescription drug claims, 2024
In 2024, the drug Kent D Schnell prescribed most often to Medicare patients was Atorvastatin Calcium, with 646 prescriptions and refills. In total Kent D Schnell wrote 15,070 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 646 | 1,883 | 191 | $5,014 |
| Levothyroxine Sodium Generic | 548 | 1,579 | 158 | $6,240 |
| Zolpidem Tartrate Generic | 492 | 609 | 88 | $3,095 |
| Lisinopril Generic | 356 | 971 | 102 | $2,662 |
| Alprazolam Generic | 342 | 349 | 57 | $1,489 |
| Amlodipine Besylate Generic | 336 | 924 | 101 | $2,242 |
| Pantoprazole Sodium Generic | 302 | 849 | 98 | $4,074 |
| Metformin Hcl Generic | 299 | 838 | 87 | $2,690 |
| Gabapentin Generic | 294 | 527 | 82 | $5,858 |
| Prednisone Generic | 278 | 300 | 172 | $740 |
| Cephalexin Generic | 270 | 278 | 189 | $1,566 |
| Citalopram Hbr Citalopram Hydrobromide | 269 | 534 | 63 | $1,659 |
| Glimepiride Generic | 256 | 699 | 79 | $2,837 |
| Losartan Potassium Generic | 250 | 692 | 76 | $2,900 |
| Meloxicam Generic | 220 | 466 | 66 | $911 |
Brand drugs: 1,527 claims; generic drugs: 13,487 claims; opioid claims: 467.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kent D Schnell $15.11 ($15.11 in general payments such as food, travel and fees) from 1 company. The largest payer was Lilly USA, LLC with $15.11.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 1 | $15.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.